European n/a Inactive AMR n/a Organism n/a Isolates from n/a n/a ICU Study surveillance intensive care Group226 patients publications WARN204, n/a Inactive AMR n/a Organism n/a n/a Pneumococci, n/a 227 information staphylococci, system publications (server) glycopeptides, aminoglycoside European n/a Inactive AMR n/a Organism n/a n/a Streptococcus n/a n/a GAS Study surveillance pyogenes Group204 39 countries Current AMR Funded by the n/a n/a n/a E. faecalis (127 surveillance European E. faecium (developed system Seventh E. coli against publications as part of (framework Framework K. pneumoniae the for Programme P. aeruginosa Detecting information S. aureus and and sharing S. pneumoniae Eliminating across Bacteria multinational clinical Information networks) Technology [DebugIT] project)
European ICU Study Group226 n/a Inactive AMR surveillance n/a Organism n/a Isolates from intensive care patients n/a n/a publications WARN204, 227 n/a Inactive AMR information system (server) n/a Organism n/a n/a Pneumococci, staphylococci, glycopeptides, n/a publications European GAS Study Group204 n/a Inactive AMR surveillance n/a Organism n/a n/a Streptococcus pyogenes n/a n/a (developed as part of the Detecting and Eliminating Bacteria Information Technology [DebugIT] project) 39 countries (127 Current AMR surveillance system (framework for information sharing across multinational clinical networks) Funded by the European Seventh Framework Programme n/a n/a n/a E. faecalis E. faecium E. coli K. pneumoniae P. aeruginosa S. aureus S. pneumoniae against and publications aminoglycoside
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx